Literature DB >> 7978935

Deeply infiltrating endometriosis is a disease whereas mild endometriosis could be considered a non-disease.

P R Koninckx1, D Oosterlynck, T D'Hooghe, C Meuleman.   

Abstract

Deeply infiltrating endometriosis can be defined as endometriosis infiltrating deeper than 5 mm under the peritoneal surface. Type I is a conical lesion suggested to be caused by infiltration; type II is mainly caused by retraction of the bowel over the lesion; type III is the most severe lesion suggested to be caused by adenomyosis externa. Severe cases are clinically apparent by nodularities in the pouch of Douglas, whereas mild and subtle forms of deep endometriosis are easily missed. Clinical examination during menstruation and scrutiny at laparoscopy for indurations, followed, preferably, by CO2-laser-excision are the key features for diagnosis and treatment. It is important to realize that depth of infiltration and lateral spread cannot be evaluated by laparoscopic inspection but only during excision, that CA125 concentration but not ultrasound or nuclear magnetic resonance can be helpful in the diagnosis, and that in the most severe cases medical pretreatment is advocated. Results of excision, as evaluated by disappearance of pain in some 80% of women, by a cumulative pregnancy of some 70% and a low recurrence rate, are excellent. The peritoneal fluid is thought to play a key role in the physiopathology of deep endometriosis which is considered to be endometriosis which has escaped from the influence of the peritoneal fluid. This concept is clinically important for the medical treatment of endometriosis, which is suggested to shrink deep lesions and to bring them back under peritoneal fluid control. A model of endometriosis is proposed and discussed. Subtle lesions are considered a natural condition occurring intermittently in all women, whereas we question whether mild endometriosis is a disease. In some women endometriosis has an aggressive behavior and develops into cystic ovarian endometriosis or into deeply infiltrating endometriosis. In this model subtle and mild forms would be called "endometriosis," whereas deep and cystic ovarian forms could be called "endometriotic disease." It is stressed that deep and cystic ovarian endometriosis are two distinct entities, which is important for our understanding of endometriosis, for classification and for treatment of endometriosis.

Entities:  

Mesh:

Year:  1994        PMID: 7978935     DOI: 10.1111/j.1749-6632.1994.tb21763.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  14 in total

Review 1.  Current drug therapy recommendations for the treatment of endometriosis.

Authors:  A Bergqvist
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

2.  Endometriosis for the colorectal surgeon.

Authors:  Katrina Slaughter; Rajiv B Gala
Journal:  Clin Colon Rectal Surg       Date:  2010-06

Review 3.  Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications.

Authors:  Pamela Stratton; Karen J Berkley
Journal:  Hum Reprod Update       Date:  2010-11-23       Impact factor: 15.610

4.  Peri-operative outcomes of patients with stage IV endometriosis undergoing robotic-assisted laparoscopic surgery.

Authors:  Lorna A Brudie; Giorgia Gaia; Sarfraz Ahmad; Neil J Finkler; Glenn E Bigsby; Giselle B Ghurani; James E Kendrick; Joseph A Rakowski; Jessica H Groton; Robert W Holloway
Journal:  J Robot Surg       Date:  2011-10-02

5.  Differences in characteristics among 1,000 women with endometriosis based on extent of disease.

Authors:  Ninet Sinaii; Katherine Plumb; Louise Cotton; Ann Lambert; Stephen Kennedy; Krina Zondervan; Pamela Stratton
Journal:  Fertil Steril       Date:  2007-05-11       Impact factor: 7.329

6.  A population-based case-control study of urinary bisphenol A concentrations and risk of endometriosis.

Authors:  Kristen Upson; Sheela Sathyanarayana; Anneclaire J De Roos; Holger M Koch; Delia Scholes; Victoria L Holt
Journal:  Hum Reprod       Date:  2014-09-09       Impact factor: 6.918

7.  Developing symptom-based predictive models of endometriosis as a clinical screening tool: results from a multicenter study.

Authors:  Kelechi E Nnoaham; Lone Hummelshoj; Stephen H Kennedy; Crispin Jenkinson; Krina T Zondervan
Journal:  Fertil Steril       Date:  2012-05-30       Impact factor: 7.329

8.  Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials.

Authors:  Christoph Gerlinger; Ulrike Schumacher; Thomas Faustmann; Antje Colligs; Heinz Schmitz; Christian Seitz
Journal:  Health Qual Life Outcomes       Date:  2010-11-24       Impact factor: 3.186

9.  Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis.

Authors:  Jodie N Painter; Carl A Anderson; Dale R Nyholt; Stuart Macgregor; Jianghai Lin; Sang Hong Lee; Ann Lambert; Zhen Z Zhao; Fenella Roseman; Qun Guo; Scott D Gordon; Leanne Wallace; Anjali K Henders; Peter M Visscher; Peter Kraft; Nicholas G Martin; Andrew P Morris; Susan A Treloar; Stephen H Kennedy; Stacey A Missmer; Grant W Montgomery; Krina T Zondervan
Journal:  Nat Genet       Date:  2010-12-12       Impact factor: 38.330

10.  Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial.

Authors:  P R Koninckx; M Craessaerts; D Timmerman; F Cornillie; S Kennedy
Journal:  Hum Reprod       Date:  2008-06-12       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.